Nuzenio

Tipranks Context Therapeutics

Tipranks Context Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Zevra Therapeutics price target lowered to $24 from $27 at BTIG - tipranks.comtipranks.com · Fri, 07 Aug 2026 16:45:41 GMTContext Therapeutics price target lowered to $3 from $4 at Citizens - tipranks.comtipranks.com · Thu, 06 Aug 2026 23:15:10 GMTContext downgraded to Market Perform from Outperform at LifeSci Capital - tipranks.comtipranks.com · Thu, 06 Aug 2026 23:15:10 GMTAnalyst Reaffirms Buy on Context Therapeutics, Citing Undervalued Pipeline and CTIM-76 as Key Long-Term Driver - tipranks.comtipranks.com · Thu, 06 Aug 2026 17:52:17 GMTAnalyst Reiterates Buy on CTI with Unchanged $5 Price Target, Citing CTIM-76 Differentiation and Strategic Focus on CT-202 - tipranks.comtipranks.com · Thu, 06 Aug 2026 10:36:07 GMTContext Therapeutics Receives Nasdaq Minimum Bid Price Notice - The Globe and MailThe Globe and Mail · Sat, 01 Aug 2026 20:34:00 GMT

Timeline

Fri, 07 Aug 2026 16:45:41 GMTZevra Therapeutics price target lowered to $24 from $27 at BTIG - tipranks.com
Thu, 06 Aug 2026 23:15:10 GMTContext Therapeutics price target lowered to $3 from $4 at Citizens - tipranks.com
Thu, 06 Aug 2026 23:15:10 GMTContext downgraded to Market Perform from Outperform at LifeSci Capital - tipranks.com
Thu, 06 Aug 2026 17:52:17 GMTAnalyst Reaffirms Buy on Context Therapeutics, Citing Undervalued Pipeline and CTIM-76 as Key Long-Term Driver - tipranks.com
Thu, 06 Aug 2026 10:36:07 GMTAnalyst Reiterates Buy on CTI with Unchanged $5 Price Target, Citing CTIM-76 Differentiation and Strategic Focus on CT-202 - tipranks.com
Sat, 01 Aug 2026 20:34:00 GMTContext Therapeutics Receives Nasdaq Minimum Bid Price Notice - The Globe and Mail

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tipranks Context Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.